CASE Op-Ed in Townhall: Live Nation Led the Anti-Trump Resistance, Now They Want Trump to Save Them
Among the more bizarre yet thoroughly amusing moments from the 2024 campaign was the video footage of President Biden...
CASE Op-Ed in The Washington Times: Biden’s Economic Incompetence on Full Display at SEC
Commission’s war on companies and tokens has hamstrung crypto industry Is it incompetence or intentional? That question becomes unavoidable when...
CASE Op-Ed in DC Journal: Consumers Can Make Their Own Grocery List Without Government Interference
“Eat your peas!” While those words may be rooted in love when your mother says them, love is the last...
CASE Op-Ed in The Kansas City Star: Why is Rep. Jason Smith working against the interests of Missouri small businesses?
Missourians know small and family-owned businesses are the main drivers of our state economy. Small businesses in the Show-Me State...
CASE Op-ed – RealClear Markets: The SEC’s Reckless Crusade to Crush the Cryptocurrency Market
September 26, 2022 The laws of physics dictate that nature abhors a vacuum, an interesting phenomena considering how many federal...
CASE Op-Ed – Inside Sources: Americans Deserve a Fair Fight Against Big Tech
April 1, 2022 To borrow from Ben Franklin, nothing is certain except death, taxes, and that Big Tech is...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/